by wpengine | Dec 6, 2017 | Stories
By John Quinn Like many people with ALS, I first noticed symptoms several months before I was diagnosed. In December 2015, I was dropping my right foot when I walked and began fatiguing more easily than normal. I went to multiple doctors and finally saw a neurologist...
by Elise Bernard | Sep 19, 2017 | Inspiring PALS, News
After 46 years of teaching, Lois Albright retired, and she and her husband moved from their home in Brenham, Texas to Austin to be closer to family. Her daughters had been encouraging her to retire for many years, but she loved to teach. “People who retire just get...
by Tanner Hockensmith | May 6, 2017 | Research, Research News
Based on information as of 5/5/2017 What is Radicava? Radicava™ (edaravone) is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) to treat people with amyotrophic lateral sclerosis (ALS).1 In clinical trials, some people given Radicava...
by Tanner Hockensmith | May 5, 2017 | Research, Research News
Radicava is First Approved Treatment for ALS in Decades The Food and Drug Administration’s (FDA) announced today that it has approved Radicava (edaravone), the first new treatment approved specifically for ALS in 22 years. The FDA approved Radicava less than a year...
by Elise Bernard | Dec 20, 2016 | Research
The ALS Association funds the world’s largest ALS research program, working with more than 150 labs around the globe. The ALS Association supports a wide breadth of specific fields of study that are critical to advancing ALS research. A significant portion of the...
